Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $79.00 USD
Change Today +1.14 / 1.46%
Volume 756.1K
CLVS On Other Exchanges
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Erle T. Mast

Co-Founder, Chief Financial Officer, Executive Vice President and Secretary,Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Erle T. Mast co-founded Clovis Oncology, Inc. on April 20, 2009, and has been its Chief Financial Officer and Executive Vice President since April 20, 2009. Mr. Mast served as the Principal Accounting Officer and Secretary of Clovis Oncology, Inc. He served as the Chief Financial Officer of Pharmion LLC (formerly, Pharmion Corporation) from July 2002 to May 2008. He served as Principal Accounting Officer of Pharmion LLC until March 2008 and served as its Executive ...

Read Full Background

Corporate Headquarters*

2525 28th Street
Boulder, Colorado 80301

United States

Phone: 303-625-5000
Fax: 303-245-0360

Board Members Memberships*

Independent Director, Chairman of Audit Committee and Member of Nominating/Corporate Governance Committee


California State University, Bakersfield

Other Affiliations*

Annual Compensation*

Total Annual Compensation$575,217

Stock Options*

All Other Compensation$15,146
Exercisable Options131,841
Exercisable Options Value$5,604,964
Unexercisable Options132,124
Unexercisable Options Value$2,158,121
Total Value of Options$7,763,084
Total Number of Options263,965

Total Compensation*

Total Annual Cash Compensation$590,363
Total Short Term Compensation$575,217
Other Long Term Compensation$15,146
Total Calculated Compensation$3,812,540
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $79.00 USD +1.14


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at